glp 1 access Medicare GLP-1 Drug Coverage CMS Expands Access to GLP-1
Description
Unlike other medications that may contribute to weight gain, GLP-1 medications help in losing weight by working with your bodys natural systems
March 2018
In a landmark development, liraglutide (Saxenda) was approved in 2020 for use in adolescents aged 12-17 years with a body weight above 60 kg and an initial BMI corresponding to 30 kg/m for adults [17]
We treat it as part of a comprehensive obesity strategy that has to work for real people across a full workforce, including people using GLP-1s, people considering them, and people who wont use them
They may find relief from supplements like Beano
